Ali Badiee - Nanotechnology

Author Information

Ali Badiee is affiliated with the Nanotechnology Research Center at the Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. He also serves in the Department of Pharmaceutical Nanotechnology at the School of Pharmacy within the same university. His research largely focuses on the development of nanotechnological solutions for medical applications, particularly in treating cancers and autoimmune diseases.

Research Contributions

Ali Badiee has made significant contributions to the field of nanotechnology, particularly in the development and application of nanocarriers and liposomal formulations for the treatment of various diseases. His recent work includes advancements in nanoparticle-mediated approaches for brain cancer treatment, restoration of multiple sclerosis, and the development of liposomal therapeutics for breast cancer and melanoma. His research has been pivotal in creating stable, high-loaded liposomal formulations and understanding their therapeutic effects both in vitro and in vivo.

Aliases

Ali Badiee is also known by the aliases "A. Badiee" and "Ali Badiee."

Publication and Citation Metrics

Metric	Value
Total Papers	126
Total Citations	2570
h-index	30

Publications:

Nanocarriers Call the Last Shot in the Treatment of Brain Cancers

DOI: 10.1177/15330338221080974

Year: 2022

Recent advancements in nanoparticle-mediated approaches for restoration of multiple sclerosis.

DOI: 10.1016/j.jconrel.2022.02.009

Year: 2022

An insight into the role of liposomal therapeutics in the reversion of multiple sclerosis

DOI: 10.1080/17425247.2021.2003327

Year: 2021

Development of a stable and high loaded liposomal formulation of lapatinib with enhanced therapeutic effects for breast cancer in combination with Caelyx®: In vitro and in vivo evaluations.

DOI: 10.1016/j.colsurfb.2021.112012

Year: 2021

Comparison of two routes of administration of a cationic liposome formulation for a prophylactic DC vaccination in a murine melanoma model.

DOI: 10.1016/j.intimp.2021.107833

Year: 2021

Development of a novel formulation method to prepare liposomal Epacadostat.

DOI: 10.1016/j.ejps.2021.105954

Year: 2021

AE36 HER2/neu-derived peptide linked to positively charged liposomes with CpG-ODN as an effective therapeutic and prophylactic vaccine for breast cancer

DOI: 10.1016/j.jddst.2021.102904

Year: 2021

pH-sensitive PEGylated liposomal silybin: Synthesis, in vitro and in vivo anti-tumor evaluation.

DOI: 10.1016/j.xphs.2021.08.015

Year: 2021

Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide

DOI: 10.1080/1061186X.2020.1870230

Year: 2021

Sphingomyelin liposome bearing whole Leishmania lysate antigens induce strong Th2 immune response in BALB/c mice

DOI: 10.22038/IJBMS.2020.50471.11496

Year: 2021

Why are Surface Charges Important in Nanotechnology?

What are Channel Dimensions?

How is it related to Nanotechnology?

What are Biodegradable Composites?

How Do Nano-Pesticides Work?

What Tools and Techniques are Used for Calibration?

How Do AI-Driven Nanosensors Work?

What Are the Key Problem-Solving Capabilities in Nanotechnology?

How Do Gold Nanoparticle Based Sensors Work?

What are some notable achievements of CNS?

Partnered Content Networks

Relevant Topics